SciSparc to Commence Its Clinical Trial with SCI-210 in Chil

“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel TEL AVIV, Israel, July 14, 2023 -- SciSparc Ltd. , a specialty...

Related Keywords

Israel , Israeli , Magister Landsheft , Yuval Landsheft , Oz Adler , National Autism Research Center , Nasdaq , Israeli Medical Cannabis Agency , Soroka University Medical Center Ethics Committee , Israeli Ministry Of Health , Scisparc Ltd , Exchange Commission , Company Or Scisparc , Israeli Ministry , Chief Executive Officer , Aberrant Behavior Checklist Community , Clinical Global Impressions Improvement , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Markets ,